February 2022: SoftPulse™ by Datwyler

Our Innovation of the Month enables the next generation of brain-monitoring devices: SoftPulse™

Our Innovation of the Month enables the next generation of brain-monitoring devices: SoftPulse™ by Datwyler!

Datwyler’s soft dry electrodes offer high wearing comfort, are waterproof, flexible, and biocompatible.

Innovative solution for long-term bio-monitoring applications.

The SoftPulse™ allows dry signal acquisition which eliminates the use of gels and decreases skin irritation significantly. The specific design and characteristics allow usage without special skin preparation and freedom of area for monitoring. It simplifies the correct placement and the patients can apply the electrodes outside the hospital, which significantly increases convenience.

Furthermore, the soft dry electrodes are very robust, can be cleaned easily and used repeatedly. The SoftPulse™ is our solution for long-term bio-monitoring applications as they really improve the treatment comfort for patients.

If you would like to learn more about SoftPulse™, you are lucky: Datwyler is partnering with WT | Wearable Technologies again at the WT | Show at MEDICA 2022! Come and visit us and get introduced to Datwyler!

If you would like to learn more about SoftPulseTM and how they are manufactured and used, visit the WT | Studio Masterclass with Datwyler.

Want to learn more about Datwyler directly? Visit their Website.

Sam Draper
February 20, 2022

February 2022

Innovation of the Month

Do you want to discover more, visit the website
Visit Website

Other news

Google Acquires Wearable Giant Fitbit for $2.1 Billion

Google announced that it is buying Fitbit, the world's leading maker of wearable fitness...

HID Global Employing Wearable Nymi Band For Employee Authentication

HID Global announced that its next-generation Seos credential technology will enable Nymi Band 3....

Revibe is a Fitbit-Like Wearable that Vibrates to Refocus Wearers’ Attention

Many students, especially younger ones, struggle to stay focused in the classroom.

Medopad Raises $25M in Series B Funding to Further Develop its Digital Health Platform

Medopad, the U.K. startup that’s seeking to battle Alzheimer's with artificial intelligence...
Discover more